Sang Moo Lim Selected Research

Sang Moo Lim Research Topics

Disease

35	Neoplasms (Cancer) 08/2022 - 01/2004
11	Osteosarcoma (Osteogenic Sarcoma) 10/2021 - 05/2013
6	Breast Neoplasms (Breast Cancer) 02/2022 - 04/2014
6	Hepatocellular Carcinoma (Hepatoma) 02/2015 - 12/2004
5	Alzheimer Disease (Alzheimer's Disease) 04/2020 - 03/2017
5	Neoplasm Metastasis (Metastasis) 12/2014 - 01/2008
4	Lymphoma (Lymphomas) 05/2021 - 01/2013
4	Glioma (Gliomas) 10/2012 - 04/2010
3	Prostatic Neoplasms (Prostate Cancer) 12/2021 - 12/2020
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 01/2013
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2016 - 10/2008
2	Brain Neoplasms (Brain Tumor) 09/2021 - 01/2007
2	Cognitive Dysfunction 04/2020 - 03/2017
2	Stomach Neoplasms (Stomach Cancer) 09/2019 - 02/2019
2	Alopecia (Baldness) 02/2019 - 02/2019
2	Thyroid Neoplasms (Thyroid Cancer) 02/2019 - 03/2010
2	Myocardial Infarction 01/2018 - 01/2012
2	Infections 08/2012 - 03/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2010 - 04/2008
1	Disease Progression 02/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2021
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2020
1	Dementia (Dementias) 01/2020
1	Chemotherapy-Related Cognitive Impairment 02/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Essential Tremor (Essential Tremors) 01/2018

Drug/Important Bio-Agent (IBA)

15	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2021 - 12/2004
7	Fluorine-18IBA 12/2016 - 09/2012
7	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 12/2004
5	Radioisotopes (Radionuclides)IBA 11/2019 - 03/2010
4	AcidsIBA 02/2022 - 12/2014
4	Trastuzumab (Herceptin)FDA Link 02/2022 - 02/2019
4	AntigensIBA 12/2021 - 09/2019
4	Tyrosine (L-Tyrosine)FDA Link 09/2021 - 08/2009
4	Rituximab (Mabthera)FDA Link 05/2020 - 01/2013
4	Monoclonal AntibodiesIBA 11/2019 - 01/2013
4	Peptides (Polypeptides)IBA 03/2019 - 01/2013
4	Therapeutic UsesIBA 02/2019 - 03/2006
3	human ERBB2 proteinIBA 02/2022 - 09/2016
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022 - 02/2013
3	18F-FC119SIBA 04/2020 - 03/2017
3	Amyloid (Amyloid Fibrils)IBA 04/2020 - 01/2018
3	ThymidineIBA 01/2017 - 05/2007
3	IntegrinsIBA 08/2016 - 01/2013
3	Biological ProductsIBA 01/2013 - 12/2004
2	Amino Acids FDA Link 09/2021 - 08/2009
2	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2021 - 08/2016
2	LigandsIBA 01/2021 - 12/2020
2	Atorvastatin (Lipitor)FDA Link 05/2020 - 02/2019
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 04/2020 - 03/2017
2	131I-rituximabIBA 12/2019 - 04/2013
2	Amyloid beta-PeptidesIBA 03/2019 - 03/2017
2	Chelating AgentsIBA 02/2019 - 01/2016
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2019 - 10/2016
2	ErbB Receptors (EGF Receptor)IBA 02/2019 - 01/2010
2	alovudineIBA 01/2017 - 08/2009
2	aspartic acid glycine arginineIBA 08/2016 - 01/2013
2	Ganciclovir (Cytovene)FDA LinkGeneric 02/2015 - 11/2010
2	Fetal Proteins (Fetoprotein)IBA 02/2015 - 08/2012
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2015 - 08/2012
2	GadoliniumIBA 12/2014 - 02/2013
2	arginyl-glycyl-aspartic acidIBA 12/2014 - 01/2013
2	NucleosidesIBA 03/2012 - 08/2009
2	fialuridineIBA 03/2012 - 06/2010
2	Thymidine KinaseIBA 03/2012 - 11/2010
1	Adenine FDA LinkGeneric 08/2022
1	64Cu-DOTA-trastuzumabIBA 02/2022
1	AlbuminsIBA 12/2021
1	LutetiumIBA 12/2021
1	GalliumIBA 12/2021
1	64Cu-DOTA-rituximabIBA 05/2021
1	Urea (Carbamide)FDA LinkGeneric 12/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	Phosphates (Orthophosphate)IBA 03/2019
1	IronIBA 02/2019
1	AntioxidantsIBA 02/2019
1	Thyroglobulin FDA Link 02/2019
1	IodineIBA 02/2019
1	CurcuminIBA 01/2018
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018
1	benzylguanidineIBA 01/2018
1	Dimethylnitrosamine (Nitrosodimethylamine)IBA 01/2018
1	Lactulose (Duphalac)FDA LinkGeneric 01/2018
1	3-Iodobenzylguanidine (Iobenguane)IBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018

Therapy/Procedure

16	Therapeutics 02/2022 - 03/2006
14	Neoadjuvant Therapy 10/2021 - 05/2013
10	Radioimmunotherapy 05/2020 - 01/2013
8	Drug Therapy (Chemotherapy) 02/2022 - 10/2013
3	Radiotherapy 12/2021 - 03/2010
2	Immunotherapy 05/2021 - 11/2019
2	Adjuvant Chemotherapy 01/2020 - 12/2014
1	Castration 12/2021
1	Precision Medicine 12/2021
1	Injections 09/2019
1	Catheters 08/2019